| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/18/2004 | WO2004022759A2 Method for improving corn starch extractability |
| 03/18/2004 | WO2004022757A1 A anemone fluoresent protein and its clone, expression and use |
| 03/18/2004 | WO2004022755A2 Polypeptides involved in the regulation of flowering in forage grasses |
| 03/18/2004 | WO2004022753A1 Novel actin-associated cytosekelton protein lacs |
| 03/18/2004 | WO2004022752A1 Smg-1-binding protein and method of screening substance controlling its activity |
| 03/18/2004 | WO2004022751A1 Cnidarian cytotoxin gene and its expression and application |
| 03/18/2004 | WO2004022750A1 Novel diagnostic and therapeutic methods and reagents therefor |
| 03/18/2004 | WO2004022747A1 Rational directed protein evolution using two-dimensional rational mutagenesis scanning |
| 03/18/2004 | WO2004022746A1 In vitro peptide expression libraray |
| 03/18/2004 | WO2004022740A1 Satellite rnas and method of controlling cucumber mosaic virus using the same |
| 03/18/2004 | WO2004022737A1 Method of designing physiologically active peptide and use thereof |
| 03/18/2004 | WO2004022736A1 Method of targeted gene disruption, genome of hyperthermostable bacterium and genome chip using the same |
| 03/18/2004 | WO2004022723A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 03/18/2004 | WO2004022719A2 Type 2 diabetes susceptibility genes |
| 03/18/2004 | WO2004022716A2 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 03/18/2004 | WO2004022715A2 Cloning and characterization of the broad-spectrum resistance gene pi2 |
| 03/18/2004 | WO2004022710A2 Methods of modulating cell death based on the bit1/aes regulatory pathway |
| 03/18/2004 | WO2004022709A2 Epitope sequences |
| 03/18/2004 | WO2004022708A2 Genes and proteins altering tau-related neurodegeneration |
| 03/18/2004 | WO2004022706A2 Immune cell receptor ligand and immune cell receptor |
| 03/18/2004 | WO2004022705A2 Neurotransmission-associated proteins |
| 03/18/2004 | WO2004022702A2 Methods and reagents for identifying inhibitors of viral protease activity. |
| 03/18/2004 | WO2004022700A2 Antifreeze proteins isolated from forage grasses and methods for their use |
| 03/18/2004 | WO2004022697A2 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof |
| 03/18/2004 | WO2004022657A2 Increasing of the resorption of substances via skin and mucous membranes |
| 03/18/2004 | WO2004022630A2 Water-soluble polymer alkanals |
| 03/18/2004 | WO2004022598A1 Fused protein with the function of both hemolysis and anticoagulation and the use of it |
| 03/18/2004 | WO2004022594A2 Immune modulatory compounds and methods |
| 03/18/2004 | WO2004022593A2 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
| 03/18/2004 | WO2004022591A1 Akap18 delta, a novel splicing variant of a protein kinase a anchor protein and the use of the same |
| 03/18/2004 | WO2004022590A2 Immunogenic muc1 glycopeptides |
| 03/18/2004 | WO2004022589A1 Tumor tag and the use thereof |
| 03/18/2004 | WO2004022588A1 Variants of the major allergen phl p 1 from timothy grass |
| 03/18/2004 | WO2004022587A2 A pair of polypeptides with specific and strong interaction |
| 03/18/2004 | WO2004022585A1 Hbv precore protein capable of forming particles |
| 03/18/2004 | WO2004022584A1 Fiber-shaping peptides capable of interacting with self-assembling peptides |
| 03/18/2004 | WO2004022581A1 Process for protein extraction |
| 03/18/2004 | WO2004022580A2 Bh3 peptides and method of use thereof |
| 03/18/2004 | WO2004022578A2 Methods, compositions and libraries pertaining pna dimer and pna oligomer synthesis |
| 03/18/2004 | WO2004022577A2 Long acting erythropoietins that maintain tissue protective activity of endogenous erythropoietin |
| 03/18/2004 | WO2004022576A2 Short peptides from the '2nd loop' of 7 transmembrane receptor which selectively modulate signal transduction |
| 03/18/2004 | WO2004022104A2 Foxp2 and uses thereof |
| 03/18/2004 | WO2004022103A2 Foxp1 and uses thereof |
| 03/18/2004 | WO2004022094A1 Allergy vaccines |
| 03/18/2004 | WO2004022089A1 Minibrain homologous proteins involved in the regulation of energy homeostasis |
| 03/18/2004 | WO2004022088A1 Interferon and immunoglobulin fc fragment hybrid |
| 03/18/2004 | WO2004022087A1 Use of disease-associated gene |
| 03/18/2004 | WO2004022086A1 Adrenocortical hormone secretion controller |
| 03/18/2004 | WO2004022084A1 A method of modulating cellular activity and molecules for use therein |
| 03/18/2004 | WO2004022082A1 Embryo implantation inhibitor |
| 03/18/2004 | WO2004022059A2 Use of 6 amino-quinoline-5, 8 quinones and nucleic acids associated with senescence for the treatment of tumors |
| 03/18/2004 | WO2004022004A2 Modified glp-1 receptor agonists and their pharmacological methods of use |
| 03/18/2004 | WO2004022003A2 Materials and methods for treatment of allergic diseases |
| 03/18/2004 | WO2004021993A2 Modified asialo-interferons and uses thereof |
| 03/18/2004 | WO2004021977A2 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
| 03/18/2004 | WO2004021871A2 Hcv assay |
| 03/18/2004 | WO2004021861A2 Targeted release |
| 03/18/2004 | WO2004021781A2 Cryptophlebia leucotreta granulovirus (crlegv-sa) as a biological control agent |
| 03/18/2004 | WO2004015098A3 Rhesus epithelial cell adhesion molecule, nucleic acid encoding the same, and uses thereof |
| 03/18/2004 | WO2004011601A8 Corn event pv-zmir13 (mon863) plants and compositions and methods for detection thereof |
| 03/18/2004 | WO2004009845A3 Methods of screening for schizophrenia |
| 03/18/2004 | WO2004009841A3 Method of identifying genes involved in cell growth regulation |
| 03/18/2004 | WO2004009631A3 Human gnrh (type 2) receptor |
| 03/18/2004 | WO2004009116A3 Hapten-carrier conjugates comprising virus like particles and uses thereof |
| 03/18/2004 | WO2004008103A3 Mutations of voltage-gated potassium channels |
| 03/18/2004 | WO2004007712A3 Modulating developmental pathways in plants |
| 03/18/2004 | WO2004006952A3 Therapeutic tuberculosis vaccines |
| 03/18/2004 | WO2004001422A3 Diagnostic and therapeutic use of ras-gtpase-activating sh3-domain-binding protein 2 (g3bp2) for neurodegenerative diseases |
| 03/18/2004 | WO2004000204A8 Labelled somatostatin analogs backbone cyclized through metal complexation |
| 03/18/2004 | WO2003102127A3 Human 5-ht7 receptor promoter sequence |
| 03/18/2004 | WO2003100004A3 A novel g protein-coupled receptor, gave2 |
| 03/18/2004 | WO2003099995A3 Murine ortholog of the human disrupted-in-schizophrenia 1 gene |
| 03/18/2004 | WO2003099322A3 Il-11 derivatives and therapeutic uses thereof |
| 03/18/2004 | WO2003097690A3 Pth derivatives resistant to skin proteases |
| 03/18/2004 | WO2003097673A3 Chimeric human papillomavirus 16 l1 proteins comprising an l2 peptide,virus-like particles prepared therefrom and a method for preparing the particles. |
| 03/18/2004 | WO2003097669A3 Method for purifying denatured proteins having a desired disulfide bond configuration |
| 03/18/2004 | WO2003093307A3 Mycobacterial antigens and uses thereof |
| 03/18/2004 | WO2003091388A3 Polymorphic olfactory receptor genes and arrays, kits and methods utilizing them |
| 03/18/2004 | WO2003091279A3 COMBINATION VACCINES INCLUDING IMMUNOGENIC GapC AND CAMP FACTOR POLYPEPTIDES |
| 03/18/2004 | WO2003089594A3 A device and methods for concentrating prion protein isoforms |
| 03/18/2004 | WO2003087149A3 Bacillus licheniformis mutant host cell |
| 03/18/2004 | WO2003087148A3 Bacillus licheniformis mutant host cell |
| 03/18/2004 | WO2003087146A3 Purified polypeptides from s. aureus, h. pylori and e. coli involved in cellular transport and metabolism |
| 03/18/2004 | WO2003087143A3 Human polypeptides having antibacterial activity |
| 03/18/2004 | WO2003087142A3 Bacillus licheniformis mutant host cell |
| 03/18/2004 | WO2003082916A3 Tumour associated antigens |
| 03/18/2004 | WO2003078462A3 Cells transfected with a nucleotide sequence encoding glp-1 and secreting insulin in a glucose-dependent manner |
| 03/18/2004 | WO2003076950A3 Screening method for identifying protective substances for treating neurodegenerative and/or ischemic disorders |
| 03/18/2004 | WO2003076461A3 Dimeric tf antagonist comprising two factor vii polypeptides |
| 03/18/2004 | WO2003075944A3 Interferon beta-like molecules for treatment of stroke |
| 03/18/2004 | WO2003072751A3 Expression system for human brain-specific voltage-gated sodium channel, type 1 |
| 03/18/2004 | WO2003072603A3 Long pentraxin ptx3 functional derivatives for preparing an autologous vaccine for the treatment of tumours |
| 03/18/2004 | WO2003070965A3 The eaat2 promoter and uses thereof |
| 03/18/2004 | WO2003054197A3 A library of modified structural genes or capsid modified particles useful for the identification of viral clones with desired cell tropism |
| 03/18/2004 | WO2003048361A3 P55pik |
| 03/18/2004 | WO2003044172B1 Composition comprising and method of using angiopoietin-like protein 3 angptl3 |
| 03/18/2004 | WO2003042226A3 Single nucleotide polymorphisms in gh-1 |
| 03/18/2004 | WO2003040305A3 Porcine adenovirus e1 and e4 regions |
| 03/18/2004 | WO2003035688A3 Targeted thrombosis by tissue factor polypeptides |
| 03/18/2004 | WO2003032813A3 Methods for the treatment of carcinoma |